Skip to main content
Contact Us
Subscribe
E-Edition
58°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Cutest Couple
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Arcturus Therapeutics Holdings Inc.
< Previous
1
2
3
Next >
Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 20, 2022
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Tickers
ARCT
Arcturus Therapeutics Announces First Quarter 2022 Financial Update and Pipeline Progress
May 09, 2022
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Tickers
ARCT
Arcturus Reports Strong Three-Month Durability Results from ARCT-154 Booster Trial
May 05, 2022
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Tickers
ARCT
Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
April 22, 2022
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Tickers
ARCT
Arcturus Announces Self-amplifying COVID-19 mRNA Vaccine Candidate ARCT-154 Meets Primary Efficacy Endpoint in Phase 3 Study
April 20, 2022
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Tickers
ARCT
Arcturus Therapeutics to Participate in the Cantor Fitzgerald Virtual Rare Orphan Disease Summit
March 25, 2022
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Tickers
ARCT
Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
March 18, 2022
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Tickers
ARCT
Arcturus Therapeutics to Participate in the Barclays Global Healthcare Conference
March 14, 2022
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Tickers
ARCT
Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 18, 2022
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Tickers
ARCT
Arcturus Therapeutics to Participate in the SVB Leerink 11th Annual Global Healthcare Conference
February 08, 2022
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Tickers
ARCT
Arcturus Therapeutics Reports New Data Demonstrating Neutralizing Antibody Immune Response to the SARS-CoV-2 Omicron Variant from ARCT-154 and ARCT-165 Booster Clinical Trial
January 25, 2022
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Tickers
ARCT
Arcturus Therapeutics Updates Data from ARCT-154 and ARCT-165 Booster Clinical Trial Demonstrating Robust Neutralizing Antibody Responses to SARS-CoV-2 and Several Variants
January 24, 2022
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Tickers
ARCT
Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 17, 2021
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Tickers
ARCT
Arcturus Therapeutics Reports New Data and Provides Additional Updates from ARCT-154 and ARCT-165 Clinical Trials
December 16, 2021
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Tickers
ARCT
Arcturus Therapeutics Appoints Jing Marantz, M.D., Ph.D., M.B.A. to its Board of Directors
December 13, 2021
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Tickers
ARCT
Arcturus Therapeutics to Participate in Piper Sandler 33rd Annual Healthcare Conference
November 22, 2021
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Tickers
ARCT
Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 18, 2021
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Tickers
ARCT
Arcturus Therapeutics Announces Third Quarter 2021 Financial Update and Pipeline Progress
November 08, 2021
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Tickers
ARCT
Arcturus Therapeutics to Report Third Quarter 2021 Financial Results and Provide Corporate Update on November 8, 2021
October 25, 2021
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Tickers
ARCT
Arcturus Therapeutics Announces Leadership Appointments
October 21, 2021
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Tickers
ARCT
Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
October 20, 2021
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Tickers
ARCT
Arcturus Therapeutics Announces Approval from Vietnam Ministry of Health to Proceed into Phase 3b Study for ARCT-154, a Next Generation STARR™ mRNA Vaccine Targeting SARS-CoV-2 Delta Variant and Other Variants of Concern
October 12, 2021
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Tickers
ARCT
Arcturus Therapeutics Announces Meeting with President of Vietnam and CEO of Vingroup to Discuss Expansion of COVID-19 Vaccine Collaboration
September 22, 2021
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Tickers
ARCT
Arcturus Therapeutics Announces Approval from Vietnam Ministry of Health to Proceed into Phase 2 and Phase 3a for ARCT-154, Next Generation STARR™ mRNA Vaccine Targeting SARS-CoV-2 Delta Variant and Other Variants of Concern
September 22, 2021
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Tickers
ARCT
Arcturus Therapeutics to Participate in Citi's 16th Annual BioPharma Virtual Conference 2021
September 08, 2021
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Tickers
ARCT
Arcturus Therapeutics to Present at Upcoming Investor and Scientific Conferences
September 07, 2021
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Tickers
ARCT
Arcturus Therapeutics Announces Second Quarter 2021 Financial Results and mRNA Vaccine and Therapeutics Pipeline Progress
August 09, 2021
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Tickers
ARCT
Arcturus Announces Approval of Singapore Clinical Trial Application to Advance ARCT-154 and ARCT-165, Next Generation STARR™ mRNA Vaccines Targeting SARS-CoV-2 Variants of Concern, in a Phase 1/2 Study
August 03, 2021
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Tickers
ARCT
Arcturus Announces Approval of a Clinical Trial Application to Advance ARCT-154, a Next Generation STARR™ mRNA Vaccine Targeting the SARS-CoV-2 Delta Variant and Other Variants of Concern
August 02, 2021
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Tickers
ARCT
Arcturus Therapeutics Collaborates with Vingroup to Establish Manufacturing Facility in Vietnam for Arcturus’ Investigational mRNA Vaccines for COVID-19
August 02, 2021
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Tickers
ARCT
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.